suPARnostic AUTO Flex ELISA
- Regulatory Status
- EU: CE
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 1 x 1h, 1 x 20min.
- Standard range
- ~1.5 - 16 ng/mL
- Specimen / Volumes
- 15 µL EDTA-plasma
- Substrate / isotope
- TMB 450nm
| instructions for use |
|---|
| instructions for use |
|---|
For in vitro diagnostic use. The suPARnostic® AUTO Flex ELISA is an in vitro diagnostic assay used to determine the soluble urokinase Plasminogen Activator Receptor (suPAR). The suPARnostic® AUTO Flex ELISA is a quantitative test measuring the suPAR level in ng/mL and is intended to aid in the detection and evaluation of inflammatory disorders and immune activation.
Indications for use
Acute medicine
For unselected acute care patients, the suPARnostic® AUTO Flex ELISA is used to identify the level of inflammation and immune activation to support triage decisions, in conjunction with clinical findings and the results of other laboratory tests.
COVID-19
In patients with confirmed COVID-19 virus, the suPARnostic® AUTO Flex ELISA is used to identify inflammation and immune activation to aid in determining the risk of respiratory failure and the need for mechanical ventilation in conjunction with clinical findings and the results of other laboratory tests.
Longevity
suPAR is a scientifically validated, clinically relevant biomarker that reflects the body’s immune activation and overall health status. By identifying hidden risks and tracking biological aging, suPAR offers a powerful tool for professionals and organizations focused on preventing chronic disease, on wellness, and on long-term vitality as such suPAR enables personalized treatment plans by providing actionable insights into patients’ biological resilience, immune health, and longterm risk, helping clinics deliver measurable outcomes to clients investing in extended healthspan.
suPAR is a marker of disease progression
suPAR is the soluble form of urokinase Plasminogen Activator Receptor (uPAR). The amount of suPAR is a measure of immune activation and chronic inflammation¹. Immune activation and chronic inflammation are drivers of disease development and disease progression.
distributed by TECAN, IBL International
For concrete data please consult the Instruction for Use in the download box on the top right side.
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
At Tecan, we are driven to improve people’s lives and health.